Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Serfaty

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Gut|June 14, 2005
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis CL Fartoux, A Poujol-Robert, J Guéchot, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Hemorrhagic ascites disclosing massive Fasciola hepatica infection]S Montembault, L Serfaty, J L Poirot, et al.
Diabetes & Metabolism|December 3, 2008
Metabolic disorders and chronic viral disease: the case of HIV and HCVL Slama, C Le Camus, L Serfaty, et al.
Gastroenterology|January 1, 1996
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activityL Serfaty, O Chazouillères, J M Pawlotsky, et al.
Clinical Chemistry|December 1, 1995
Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis CM Vaubourdolle, O Chazouillères, I Briaud, et al.
Hepatology (Baltimore, Md.)|March 1, 1995
Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening testL Serfaty, J B Nousbaum, M H Elghouzzi, et al.
Journal of Hepatology|March 29, 2000
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosisJ Guéchot, L Serfaty, A M Bonnand, et al.
Gut|February 13, 2004
Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancerY Parc, S Gueroult, N Mourra, et al.
Journal of Hepatology|August 1, 1997
Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patientsP Podevin, J Guechot, L Serfaty, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
Determinants of outcome of compensated hepatitis C virus-related cirrhosisL Serfaty, H Aumaître, O Chazouillères, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Gut|June 14, 2005
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis CL Fartoux, A Poujol-Robert, J Guéchot, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1997
[Hemorrhagic ascites disclosing massive Fasciola hepatica infection]S Montembault, L Serfaty, J L Poirot, et al.
Diabetes & Metabolism|December 3, 2008
Metabolic disorders and chronic viral disease: the case of HIV and HCVL Slama, C Le Camus, L Serfaty, et al.
Gastroenterology|January 1, 1996
Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activityL Serfaty, O Chazouillères, J M Pawlotsky, et al.
Clinical Chemistry|December 1, 1995
Plasma alpha-glutathione S-transferase assessed as a marker of liver damage in patients with chronic hepatitis CM Vaubourdolle, O Chazouillères, I Briaud, et al.
Hepatology (Baltimore, Md.)|March 1, 1995
Prevalence, severity, and risk factors of liver disease in blood donors positive in a second-generation anti-hepatitis C virus screening testL Serfaty, J B Nousbaum, M H Elghouzzi, et al.
Journal of Hepatology|March 29, 2000
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosisJ Guéchot, L Serfaty, A M Bonnand, et al.
Gut|February 13, 2004
Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancerY Parc, S Gueroult, N Mourra, et al.
Journal of Hepatology|August 1, 1997
Evidence for a deficiency of interferon response in mononuclear cells from hepatitis C viremic patientsP Podevin, J Guechot, L Serfaty, et al.
Hepatology (Baltimore, Md.)|May 15, 1998
Determinants of outcome of compensated hepatitis C virus-related cirrhosisL Serfaty, H Aumaître, O Chazouillères, et al.
Pageof 5